New diabetes clinical trial: Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults MASLD Patients (DELI_MASLD Study)
Published on: April 07, 2024 at 11:00PM
Conditions: Metabolic Dysfunction Associated Steatotic Liver Disease; Steatotic Liver Disease; Hepatic Steatosis
Interventions: Dietary Supplement: Probiotic lysate (postbiotic and metabiotc); Dietary Supplement: Placebo
Sponsors: Bogomolets National Medical University; Taras Shevchenko National University of Kyiv; Danylo Halytsky Lviv National Medical University; Kyiv City Clinical Endocrinology Center; Center for Innovative Medical Technologies of the National Academy of Sciences of Ukraine; MirImmunoFarm; Stellar Biotics
Completed
https://ift.tt/hTvIo7R
Conditions: Metabolic Dysfunction Associated Steatotic Liver Disease; Steatotic Liver Disease; Hepatic Steatosis
Interventions: Dietary Supplement: Probiotic lysate (postbiotic and metabiotc); Dietary Supplement: Placebo
Sponsors: Bogomolets National Medical University; Taras Shevchenko National University of Kyiv; Danylo Halytsky Lviv National Medical University; Kyiv City Clinical Endocrinology Center; Center for Innovative Medical Technologies of the National Academy of Sciences of Ukraine; MirImmunoFarm; Stellar Biotics
Completed
https://ift.tt/hTvIo7R
Comments
Post a Comment